Bone marrow purging by photodynamic treatment in children with acute leukemia - Cytoprotective action of Amifostine

Citation
V. Danilatou et al., Bone marrow purging by photodynamic treatment in children with acute leukemia - Cytoprotective action of Amifostine, LEUK RES, 24(5), 2000, pp. 427-435
Citations number
61
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
LEUKEMIA RESEARCH
ISSN journal
01452126 → ACNP
Volume
24
Issue
5
Year of publication
2000
Pages
427 - 435
Database
ISI
SICI code
0145-2126(200005)24:5<427:BMPBPT>2.0.ZU;2-O
Abstract
In order to evaluate the combined effect of Amifostine and Merocyanine 540 during photoirradiation in neoplastic cells, bone marrow cells from childre n with acute leukemia (AL), age-matched controls as well as HL-60 cell line were studied. Cell suspensions were incubated with Amifostine, then with M C 540 and they were subsequently exposed to different irradiation doses by Argon Laser 514 nm. Cell survival was estimated by trypan blue supravital s tain following a 24-h incubation. The leukemic cell line was studied in con tinuous liquid cell cultures for 4 weeks. The survival of normal bone marro w progenitors has been estimated by colony formation assay in methylcellulo se cultures. Our results showed that Amifostine enhances the photokilling e ffect of MC 540 on leukemic cells and significantly protects bone marrow nu cleated and committed progenitors (BFU-E and CFU-GM) from children with AL under chemotherapy. In conclusion, Amifostine seems to be a promising cytop rotective agent in the clinical use of purging with MC 540 mediated phototh erapy. (C) 2000 Elsevier Science Ltd. All rights reserved.